// App-Quantinova.ai

: MULTICENTER RETROSPECTIVE STUDY EVALUATING FIBROSIS RISK IN PATIENTS WITH ET DEPENDING ON THE TREATMENT SCENARIO

Researchers

Presenter

  • Marta Sobas

Principal Investigators

  • Magdalena Olszewska-Szopa

  • Mateusz Nowak

  • Konrad Reszka

  • Arkadiusz Drapniewski

  • Jaroslaw Czyz

  • Lukasz Szukalski

  • Aleksandra Golos

  • Anna Masternak

  • Aitor Abuin Blanco

  • Manuel Perez Encinas

  • Maria Teresa Gomez Casares

  • Maria Soledad Noya Pereira

  • Tomasz Wrbel

Medical Centers

  • Hemathology, Blood Neoplasms and Bone Marrow Transplantation,University Hospital,Wroclaw,Poland

  • WSS-OBR Hospital,Wroclaw,Poland

  • Rheumatology, University Hospital, Bydgoszcz, Poland

  • Institute of Hematology and Transfusion Medicine, Warsaw, Poland

  • Hemathology,City Hospital,Opole,Poland

  • Hemathology,University Hospital,Santiago de Compostela,Spain

  • Rheumatology, Hospital Universitario Doctor Negrin, Gran Canaria, Spain

  • Hemathology,Hospital Complejo Hospitalario Universitario,La Coruna,Spain

Locations

  • Poland

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Oncology (ONC)

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

Disease

  • Myelofibrosis

  • Venous thrombosis

Biomarkers

  • Lactate dehydrogenase

  • White Blood Cell

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved